Literature DB >> 15343344

A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication.

S J Kussick1, D L Stirewalt, H S Yi, K M Sheets, E Pogosova-Agadjanyan, S Braswell, T H Norwood, J P Radich, B L Wood.   

Abstract

In a 5-year survey of nonpromyelocytic/nonmonocytic acute myeloid leukemias (AMLs) diagnosed in the University of Washington Hematopathology Laboratory, we identified 19 cases containing distinctive, cup-like nuclear indentation in 10% or more of the blasts ('AML-cuplike'). Fourteen of these cases (74%) demonstrated near-complete loss of HLA-DR expression, while the other five cases showed partial loss of HLA-DR. A total of 16 of the cases (84%) demonstrated internal tandem duplication (ITD) of the Flt3 gene. When compared to a selected set of AMLs lacking this nuclear morphology, AML-cuplike was significantly more likely to lack HLA-DR and CD34 expression, to express CD123 without CD133, to have a normal karyotype, and to harbor the Flt3 ITD. To characterize AML-cuplike in an unselected series of AMLs, we analyzed 42 consecutive nonpromyelocytic/nonmonocytic AMLs diagnosed in our laboratory during a 6-month period in 2002. Strikingly, in this unselected series, there was a statistically significant coincidence of invaginated nuclear morphology, loss of HLA-DR, and presence of the Flt3 ITD beyond that expected if these three features were unrelated, suggesting that AMLs with these three features may represent a distinct AML subset.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343344     DOI: 10.1038/sj.leu.2403458

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  15 in total

1.  Acute myeloid leukemia-cuplike: characteristic peroxidase staining pattern.

Authors:  Akira Okano; Tohru Inaba
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

2.  Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome.

Authors:  Tohru Inaba; Hiroshi Nishimura; Junko Saito; Yoko Yamane; Takuya Nakatani; Mio Yamamoto; Hitoji Uchiyama; Naohisa Fujita
Journal:  Int J Hematol       Date:  2008-11-27       Impact factor: 2.490

3.  Acute myeloid leukemia with cuplike nuclei and intracytoplasmic inclusions following myelodysplastic syndrome.

Authors:  Masahiro Manabe; Koji Nakamura; Junko Nakamura; Tomoko Fukuyama; Erina Fukada; Hideto Senzaki; Kensuke Ohta
Journal:  Int J Hematol       Date:  2009-06-17       Impact factor: 2.490

4.  Diagnostic challenges related to myeloid/natural killer cells, a variant of myeloblasts.

Authors:  Guilin Tang; Franciose Truong; Oluwole Fadare; Bruce Woda; Sa A Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-28

5.  Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity.

Authors:  Catherine Matte-Martone; Jinling Liu; Meng Zhou; Maria Chikina; Douglas R Green; John T Harty; Warren D Shlomchik
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

6.  CD123 Expression Is Associated With High-Risk Disease Characteristics in Childhood Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Authors:  Adam J Lamble; Lisa Eidenschink Brodersen; Todd A Alonzo; Jim Wang; Laura Pardo; Lillian Sung; Todd M Cooper; E Anders Kolb; Richard Aplenc; Sarah K Tasian; Michael R Loken; Soheil Meshinchi
Journal:  J Clin Oncol       Date:  2021-12-02       Impact factor: 44.544

7.  Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation.

Authors:  Weina Chen; Sergej Konoplev; L Jeffrey Medeiros; Hartmut Koeppen; Vasiliki Leventaki; Saroj Vadhan-Raj; Dan Jones; Hagop M Kantarjian; Brunangelo Falini; Carlos E Bueso-Ramos
Journal:  Cancer       Date:  2009-12-01       Impact factor: 6.860

8.  Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication.

Authors:  Mareike Rickmann; Juergen Krauter; Kathrin Stamer; Michael Heuser; Gustavo Salguero; Eva Mischak-Weissinger; Arnold Ganser; Renata Stripecke
Journal:  Ann Hematol       Date:  2011-04-26       Impact factor: 3.673

9.  Clinical features of de novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations.

Authors:  Sanam Loghavi; Zhuang Zuo; Farhad Ravandi; Hagop M Kantarjian; Carlos Bueso-Ramos; Liping Zhang; Rajesh R Singh; Keyur P Patel; L Jeffrey Medeiros; Francesco Stingo; Mark Routbort; Jorge Cortes; Rajyalakshmi Luthra; Joseph D Khoury
Journal:  J Hematol Oncol       Date:  2014-10-04       Impact factor: 17.388

10.  Genomic alterations in abnormal neutrophils isolated from adult patients with systemic lupus erythematosus.

Authors:  Namrata Singh; Pamela Traisak; Kayla A Martin; Mariana J Kaplan; Philip L Cohen; Michael F Denny
Journal:  Arthritis Res Ther       Date:  2014-08-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.